On the other hand, selective MAO-A inhibitors are of great interest in counteracting the growth of prostate cancer cells and metastasis through the inhibition of ROS-driven pro-tumorigenic signaling pathways [12,13]. The gene discussed is MAOA; the disease is Familial prostate cancer.